GraniteShares Advisors’s Pfizer PFE Stock Holding History

GraniteShares Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,435	Closed	-$603K	–	128
2023 Q2	$603K	Sell	16,435 -468	-3%	-$18.2K	0.54%	61
2023 Q1	$690K	Sell	16,903 -235	-1%	-$10.2K	0.61%	61
2022 Q4	$878K	Sell	17,138 -3,695	-18%	-$177K	0.73%	33
2022 Q3	$911K	Sell	20,833 -3,613	-15%	-$176K	0.74%	34
2022 Q2	$1.28M	Sell	24,446 -1,150	-4%	-$58.6K	0.94%	28
2022 Q1	$1.32M	Sell	25,596 -1,115	-4%	-$57.9K	0.72%	28
2021 Q4	$1.58M	Buy	+26,711	New	+$1.32M	0.73%	29

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GraniteShares Advisors's PFE Position: Q3 2023 in Review

GraniteShares Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 16,435 shares — an estimated $603K sold.

GraniteShares Advisors first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $1.58M in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

GraniteShares Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
GraniteShares Advisors sold 16,435 Pfizer shares in Q3 2023, an estimated $603K.
GraniteShares Advisors first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
GraniteShares Advisors's Pfizer position peaked at $1.58M in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.